Table 2.

Univariate Associations between HDL Redox Activity and Demographic, Metabolic, and Immunologic/inflammatory Parameters Among All Subjects, HIV-Infected Subjects, and Non-HIV-Infected Control Subjects

	All Subjects (n=143)		HIV-Infected Subjects (n=102)		Non-HIV-Infected Control Subjects (n=41)
Demographic Parameters
Age, years	rho=0.13	p=0.14	rho=0.02	p=0.88	rho=0.31	p=0.05*
Cigarette smoking, pack-years	rho=−0.07	p=0.44	rho=−0.08	p=0.48	rho=−0.29	p=0.08
Metabolic Parameters
Body mass index, kg/m2	rho=0.17	p=0.05*	rho=0.11	p=0.30	rho=0.30	p=0.06
Systolic blood pressure, mm Hg	rho=0.04	p=0.64	rho=−0.04	p=0.67	rho=0.15	p=0.35
Total cholesterol level, mg/dL	rho=−0.03	p=0.75	rho=−0.10	p=0.35	rho=0.17	p=0.31
HDL cholesterol level, mg/dL	rho=−0.29	p=0.0007*	rho=−0.32	p=0.002*	rho=−0.17	p=0.29
LDL cholesterol level, mg/dL	r=0.08	p=0.39	r=0.03	p=0.74	r=0.27	p=0.09
Triglyceride level, mg/dL	rho=0.18	p=0.04*	rho=0.11	p=0.29	rho=0.20	p=0.23
Log adiponectin, ng/mL	r=−0.26	p=0.002*	r=−0.28	p=0.006*	r=−0.24	p=0.14
Immunologic/inflammatory Parameters
Log high-sensitivity C-reactive protein (CRP), mg/L	r=−0.10	p=0.26	r=−0.07	p=0.50	r=−0.21	p=0.19
Log high-sensitivity interleukin 6 (IL-6), pg/mL	r=−0.04	p=0.66	r=−0.03	p=0.80	r=−0.24	p=0.20
Log D-dimer, ng/mL	r=0.004	p=0.97	r=−0.004	p=0.97	r=−0.02	p=0.93
Log lipopolysacharide (LPS), ng/mL	r=0.02	p=0.86	r=−0.04	p=0.72	r=−0.03	p=0.85
Log soluble CD14 (sCD14), ng/mL	r=0.10	p=0.24	r=0.04	p=0.70	r=0.17	p=0.30
Log soluble CD163 (CD163), ng/mL	r=0.22	p=0.009*	r=0.24	p=0.02*	r=0.03	p=0.84
Duration of HIV infection, years	N/A	N/A	r=0.10	p=0.36	N/A	N/A
Duration of antiretroviral therapy, years	N/A	N/A	rho=0.19	p=0.14	N/A	N/A
Current CD4 count, cells/mm3	N/A	N/A	rho=−0.006	p=0.96	N/A	N/A
Nadir CD4 count, self-reported, cells/mm3	N/A	N/A	rho=−0.009	p=0.94	N/A	N/A
Log HIV-RNA level (viral load)	N/A	N/A	r=0.18	p=0.11	N/A	N/A